Omnicell (OMCL) Net Equity Issued and Repurchased (2019)
Omnicell's (OMCL) quarterly Net Equity Issued and Repurchased came in at $17.6 million in Q2 2019, down 12.99% quarter-over-quarter from $20.2 million in Q1 2019.
Powered by 
Analysis
Omnicell (OMCL) Net Equity Issued and Repurchased (2019) Analysis & Trends
Omnicell (OMCL) has reported Net Equity Issued and Repurchased for 1 consecutive years, with $17.6 million the latest figure, recorded in Q2 2019.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $17.6 million in Q2 2019; TTM through Mar 2020 was $17.6 million, a N/A change from a year earlier, with the FY2019 full-year figure at $37.8 million, down 4.45% from the prior year.
- Net Equity Issued and Repurchased was $17.6 million for Q2 2019 at Omnicell, down from $20.2 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $20.2 million in Q1 2019 and troughed at $17.6 million in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 29.31 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | - |